KALY Announces New HempTantation CBD Sunscreen For $17 Billion Market

Dallas, TX– May 2, 2019 – Kali-Extracts, Inc. (OTCPK: KALY)  (Kali, Inc. dba/Kali-Extracts, Inc.) (“KALY”) today announced the all new HempTantation, a hemp derived CBD infused sunscreen.  KALY has a U.S. Patented cannabis extraction process.  The company is conducting ongoing research and development with its cannabis extracts to develop a variety of pharmaceutical treatments for […]

KALY Publishes Cannabis Extract COPD Treatment Study Report

Dallas, TX – March 21, 2019 – Kali-Extracts, Inc. (OTC: KALY)  (Kali, Inc. dba/Kali-Extracts, Inc.) (“KALY”) today published the research report on the recent pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates using an extract derived from KALY’s patented cannabis extraction process.  The report details the study method and the significance of the study.  […]

Kali-Extracts Inc Announces $300,000 Contract to Produce Hemp-Derived CBD Extract for Puration Inc

Dallas, TX – December 10, 2018 – Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) today announced a $300,000 contract with Puration, Inc. (USOTC: PURA) (“PURA”) to produce custom hemp-derived CBD extracts.  Kali-Extracts recently acquired a patented cannabis extraction process, that comes with a substantial volume of associated clinical research, in a reverse merger transaction […]